申请人:Kissei Pharmaceutical Co., Ltd.
公开号:EP0357172A2
公开(公告)日:1990-03-07
Compounds of the general formula (I):
wherein
1) R¹ and R² are the same as each other, and represent a group of the formula of -OR³ in which R³ represents a carbamoyl group, an N-mono-alkylcarbamoyl group, an N,N-dialkylcarbamoyl group, an alkylsulfonyl group, a formyl group or an aliphatic acyl group which may have an alkoxycarbonyl group as a substituent; m represents zero, 1 or 2; and n represents zero or 1; with the proviso that n is not zero when m is zero; or
2) R¹ and R² are different from each other, and represent a hydroxy group or an N,N-di-alkylcarbamoyloxy group; m represents 1 or 2; and n represents 1, which are useful for the prevention or treatment of osteoporosis.
通式(I)化合物:
其中
1) R¹和 R² 彼此相同,并代表-OR³式中的一个基团,其中 R³ 代表氨基甲酰基、N-单烷基氨基甲酰基、N,N-二烷基氨基甲酰基、烷基磺酰基、甲酰基或脂肪酰基,该酰基可具有一个烷氧基羰基作为取代基;m 代表零、1 或 2;n 代表零或 1;但当 m 为零时,n 不为零;或
2) R¹ 和 R² 互不相同,代表羟基或 N,N-二烷基氨基甲酰氧基;m 代表 1 或 2;n 代表 1,可用于预防或治疗骨质疏松症。